Komori
Zeria Pharmaceutical (4559) · TargetRestated

Implementation of the 9th Medium-Term Management Plan

First written in FY2017. 10 of 14 entries say "Restated". Latest entry: FY2023-Q3.

14entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017RestatedFY2020-Q1 – FY2023-Q32017: 120172018: 220182019: 420192020: 320202021: 120212022: 220222023: 1
Same theme, other companies
Promoting continuity from the Ninth Medium-Term Management Plan to the Tenth PlanA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the third quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Tenth Medium-Term Management Plan.
  2. FY2023-Q2RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the second quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Tenth Medium-Term Management Plan.
  3. FY2022-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the third quarter of the current consolidated cumulative period.」

    It was explained that there were no material changes to the management policies, management strategies or other matters, including the Tenth Medium-Term Management Plan.
  4. FY2022-Q2RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the second quarter of the current consolidated cumulative period.」

    It was explained that there were no material changes to the management policies, management strategies or other matters, including the Tenth Medium-Term Management Plan.
  5. FY2021-Q2RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the second quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Tenth Medium-Term Management Plan.
  6. FY2020Plan period endedAnnual report

    「In the consolidated fiscal year under review, the final year of the Ninth Medium-Term Management Plan covering fiscal 2017 through fiscal 2019, the Group steadily expanded overseas sales while promoting its global expansion.」

    The Ninth Medium-Term Management Plan ended its planning period in fiscal 2019. The Company reported progress in global expansion and growth in overseas sales, but did not explicitly state that the plan as a whole had been achieved.
  7. FY2020-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the third quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Ninth Medium-Term Management Plan.
  8. FY2020-Q2RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the second quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Ninth Medium-Term Management Plan.
  9. FY2020-Q1RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the first quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Ninth Medium-Term Management Plan.
  10. FY2019AdvancedAnnual report

    「In fiscal 2019, the final year of the Ninth Medium-Term Management Plan, a three-year plan commencing in fiscal 2017 and covering fiscal 2017 through fiscal 2019, the Group will pursue active investment with the aim of improving its earnings structure at an early stage to achieve sustainable growth.」

    As the Ninth Medium-Term Management Plan approaches its final year, the Company identified early improvement of its earnings structure and active investment as key priorities.
  11. FY2019-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the third quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Ninth Medium-Term Management Plan.
  12. FY2019-Q2RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the second quarter of the current consolidated cumulative period.」

    The Company explained that there were no material changes to its management policies, management strategies or other matters, including the Ninth Medium-Term Management Plan.
  13. FY2018AdvancedAnnual report

    「The Group began the second year of the three-year Ninth Medium-Term Management Plan, commencing in fiscal 2017 and covering fiscal 2017 through fiscal 2019. In the first year, the consolidated fiscal year under review, the Group actively invested management resources to accelerate its global expansion and achieve strong growth in its prescription pharmaceutical and consumer healthcare businesses.」

    The Ninth Medium-Term Management Plan entered its second year, and the Company reported that it had invested management resources in global expansion and the growth of its 2 businesses in the first year.
  14. FY2017First statedAnnual report

    「Against this backdrop, the Group launched the three-year Ninth Medium-Term Management Plan, commencing in fiscal 2017 and covering fiscal 2017 through fiscal 2019.」

    The Company launched the three-year plan covering fiscal 2017 through fiscal 2019, following the Eighth Medium-Term Management Plan.
Moved together

"Growth of the Prescription Pharmaceutical Business Driven by Asacol, Acofide, and Entocort" moved the same way as this thread, in the same document, in 2 of its 14 moves.

222222★123456
  1. ★This thread
  2. 1Growth of the Prescription Pharmaceutical Business Driven by Asacol, Acofide, and Entocort2×
  3. 2Expansion of the Consumer Healthcare Business Centered on Hepalyse2×
  4. 3Strengthening the Consumer Healthcare Product Lineup2×
  5. 4Expansion of overseas sales2×
  6. 5Increase in the ratio of overseas sales2×
  7. 6Profit Decline Due to Increased Expenses Such as Research and Development Costs2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.